Beranda › Neuroblastoma › Hawaii › Honolulu
Uji klinis Neuroblastoma di Honolulu, HI
6 studi untuk Neuroblastoma mencari peserta di lokasi sekitar Honolulu (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Menerima pesertaFase 3
- Kapiolani Medical Center for Women and Children, Honolulu
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Menerima pesertaFase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Menerima pesertaFase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Menerima pesertaFase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Menerima pesertaFase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Menerima pesertaFase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Uji klinis Neuroblastoma di kota lain
- Boston, MA13 studi
- Washington, DC11 studi
- New York City, NY10 studi
- Dallas, TX9 studi
- Memphis, TN9 studi
- Philadelphia, PA9 studi
- St. Louis, MO9 studi
- Aurora, CO8 studi
- Hartford, CT8 studi
- Minneapolis, MN8 studi
- Birmingham, AL8 studi
- Atlanta, GA7 studi
Studi lain di Honolulu
- Kanker (semua jenis)13 studi
- Obesitas13 studi
- Kanker Payudara12 studi
- Kelebihan Berat Badan11 studi
- Kanker Paru Non-Sel Kecil10 studi
- Kanker Paru8 studi
- Leukemia Mieloid Akut7 studi
- Diabetes Tipe 27 studi
- Kanker Ovarium7 studi
- Kanker Pankreas7 studi
- Kanker Prostat5 studi
- Limfoma Burkitt5 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.